21.218 articles found

Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming.

Nakamura T, Nishijima H, Mori F, Kinoshita I, Kon T, Suzuki C, Wakabayashi K, Tomiyama M.

Front Neurosci · 2023-06-07

DOI: 10.3389/fnins.2023.1169336PMID: 37351424

Voice improvement following conventional speech therapy combined with singing intervention in people with Parkinson's disease: A three-arm randomised controlled trial.

Mohseni Z, Mohamadi R, Habibi SAH, Saffarian A, Abolghasemi J.

Int J Lang Commun Disord · 2023-06-07

DOI: 10.1111/1460-6984.12900PMID: 37282797

Repurposing Niclosamide as a plausible neurotherapeutic in autism spectrum disorders, targeting mitochondrial dysfunction: a strong hypothesis.

Varma M, Bhandari R, Kuhad A.

Metab Brain Dis · 2023-06-07

DOI: 10.1007/s11011-023-01247-xPMID: 37284987

A_2AR antagonist treatment for multiple sclerosis: Current progress and future prospects.

Qi C, Feng Y, Jiang Y, Chen W, Vakal S, Chen JF, Zheng W.

Int Rev Neurobiol · 2023-06-05

DOI: 10.1016/bs.irn.2023.05.012PMID: 37741692

Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment.

Gong Y, Chen A, Zhang G, Shen Q, Zou L, Li J, Miao YB, Liu W.

Int J Biol Sci · 2023-06-04

DOI: 10.7150/ijbs.85259PMID: 37416776

A review of studies on gut microbiota and levodopa metabolism.

Zhong Z, Ye M, Yan F.

Front Neurol · 2023-06-02

DOI: 10.3389/fneur.2023.1046910PMID: 37332996

Research methods and efficacy of acupuncture in the treatment of Parkinson's disease: a scoping review of systematic reviews and meta-analyses.

Yu B, Ma SQ, Huang HP, Zhong Z, Yu S, Huang K, Zhang LY, Li MY, Yao L.

Front Neurol · 2023-06-02

DOI: 10.3389/fneur.2023.1196446PMID: 37332994

Case report: Levodopa-responsive parkinsonism with akinetic mutism after ventriculo-peritoneal shunt.

Zhang Y, Li P, Zhang J, Li C, Sun P, Li F, Jiao Z.

Front Neurol · 2023-06-02

DOI: 10.3389/fneur.2023.1184713PMID: 37332998

TRP channels: Role in neurodegenerative diseases and therapeutic targets.

Rather MA, Khan A, Wang L, Jahan S, Rehman MU, Makeen HA, Mohan S.

Heliyon · 2023-06-02

DOI: 10.1016/j.heliyon.2023.e16910PMID: 37332910

GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics.

Ugale V, Deshmukh R, Lokwani D, Narayana Reddy P, Khadse S, Chaudhari P, Kulkarni PP.

Mol Divers · 2023-06-02

DOI: 10.1007/s11030-023-10656-0PMID: 37266849

TRP channels: Role in neurodegenerative diseases and therapeutic targets

Rather MA, Khan A, Wang L, Jahan S, Rehman MU, Makeen HA, Mohan S.

Heliyon · 2023-06-01

Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson's Disease: A Randomized Controlled Trial.

Hoffman L, Burt ND, Piniella NR, Baker M, Volino N, Yasin S, Jung MK, Leder A, Sousa A.

Parkinsons Dis · 2023-06-01

DOI: 10.1155/2023/6645554PMID: 37304831